Stock screener

STOK

Conviction 47HealthcareScan · Thu, Jun 25, 2026
STOK$30.43+0.13%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 832.83K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Stoke Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.stoketherapeutics.com
Price30.43
Change+0.13%
Gap-0.31%
Rel volume3.32×
Avg volume735.7K
Avg $ vol22.25M
SMA 2030.03
SMA 5031.72
SMA 20030.94
Price vs 50-4.07%
Price vs 200-1.66%
MA stackmixed
50/200 cross
Supertrenddown · 33.37
RSI (14)49
MACD hist0.24
MACD crossbull · 8d
Stoch %K / %D54 / 60
ADX (14)14
+DI / −DI17 / 15
RSI divergence
MACD divergence
ATR %+4.92%
ADR %4.68%
52w high38.35
52w low11.35
From 52w high-20.65%
Above 52w low+168.11%
New 52w highNo
SqueezeOn · 12d
Bollinger width11.19%
%B0.62
Donchian pos54.48%
Donchian high32.36
Donchian low28.12
AVWAP (52w high)32.56
vs AVWAP high-6.55%
AVWAP (52w low)27.60
vs AVWAP low+10.26%
OBV trendUp
Chaikin MF (20)-0.20
Today vs 20d3.32×
Avg vol (14d)832.83K
Avg vol (20d)735.7K
Avg $ vol (20d)22.25M
Market cap1.9B
RS 3m (vs SPY)-17.82%
RS 6m (vs SPY)-12.65%
RS line new highNo
Trend template4/8
Technical rank32.0
1 week+0.56%
1 month-1.93%
3 months-9.94%
6 months-9.22%
1 year+164.38%
YTD-1.52%
P/E-275.27
P/B4.80
P/S10.28
P/FCF42.20
EPS-0.1200
Div yield
ROE-1.74%
ROA-1.55%
Debt/Eq
Current8.99
EV/EBITDA
Gross margin
Net margin-3.73%
Rev growth404.50%
EPS growth92.26%
Price target47.83
Target upside57.18%
Analyst ratingBuy
Institutional122.86%
Ent. value1.74B
Revenue6.23M
Net income-50M
Gross profit
Free cash flow44.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out62.28M
Employees170
ListedWed, Jun 19, 2019
Free float49.14M
Float %86.0%
Short interest11.23M
Days to cover19.1d
Short volume77.5%
Squeeze score100 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.79 vs −$0.80
Last surprise+1.3% beat
Setup gradeC
Conviction47 / 100
Pattern quality
Tech rank32.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance34.80
Support28.07
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in STOK

All disclosures →
No recent disclosed trades by Congress in STOK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in STOK · 7 buys · 3 sells

InsiderSideShares
Allan Jonathan
GENERAL COUNSEL & CORP SEC · Common Stock · 2026-06-16
Sell1.46K
LEVIN ARTHUR A
Director · Director Stock Option (Right to Buy) · 2026-06-03
Grant17.79K
Krainer Adrian R.
Director · Director Stock Option (Right to Buy) · 2026-06-03
Grant17.79K
TZIANABOS ARTHUR
Director · Director Stock Option (Right to Buy) · 2026-06-03
Grant17.79K
Harrison Seth Loring
Director · Director Stock Option (Right to Buy) · 2026-06-03
Grant17.79K
Kaye Edward M. MD
Director · Director Stock Option (Right to Buy) · 2026-06-03
Grant17.79K
Smith Julie
Director · Director Stock Option (Right to Buy) · 2026-06-03
Grant17.79K
Burstein Jennifer
Director · Director Stock Option (Right to Buy) · 2026-06-03
Grant17.79K
Ticho Barry
CHIEF MEDICAL OFFICER · Common Stock · 2026-06-01
Sell1.79K
Ticho Barry
CHIEF MEDICAL OFFICER · Common Stock · 2026-05-01
Sell2.24K

SEC filings

EDGAR filings in STOK · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.